Opexa Therapeutics (ACER) Earns Daily News Impact Rating of 0.06


Media headlines about Opexa Therapeutics have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by reviewing more than twenty million news and blog sources.



from Biotech News